PCRX Stock Overview
Operates retail pharmacies under the PharmaChoice name in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
PharmaCorp Rx Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.52 |
| 52 Week High | CA$0.88 |
| 52 Week Low | CA$0.43 |
| Beta | -5.58 |
| 1 Month Change | -13.33% |
| 3 Month Change | -27.78% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 333.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| PCRX | CA Consumer Retailing | CA Market | |
|---|---|---|---|
| 7D | 18.2% | -1.5% | 0.4% |
| 1Y | n/a | 17.9% | 17.1% |
Return vs Industry: Insufficient data to determine how PCRX performed against the Canadian Consumer Retailing industry.
Return vs Market: Insufficient data to determine how PCRX performed against the Canadian Market.
Price Volatility
| PCRX volatility | |
|---|---|
| PCRX Average Weekly Movement | 11.0% |
| Consumer Retailing Industry Average Movement | 3.4% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: PCRX has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine PCRX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Grady Brown | n/a |
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. It offers prescription drug and custom compounding specialization services; weight loss and lifestyle management solutions, including health and wellness products; vitamins and supplements; and convenience and confectionary products. The company was incorporated in 2021 and is based in Saskatoon, Canada.
PharmaCorp Rx Inc. Fundamentals Summary
| PCRX fundamental statistics | |
|---|---|
| Market cap | CA$58.63m |
| Earnings (TTM) | -CA$1.99m |
| Revenue (TTM) | CA$1.40m |
43.7x
P/S Ratio-30.7x
P/E RatioIs PCRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PCRX income statement (TTM) | |
|---|---|
| Revenue | CA$1.40m |
| Cost of Revenue | CA$881.75k |
| Gross Profit | CA$514.09k |
| Other Expenses | CA$2.50m |
| Earnings | -CA$1.99m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.017 |
| Gross Margin | 36.83% |
| Net Profit Margin | -142.45% |
| Debt/Equity Ratio | 1.4% |
How did PCRX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/09 17:03 |
| End of Day Share Price | 2025/01/09 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
PharmaCorp Rx Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|